Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | ALK tyrosine kinase receptor [L1196M] | ||
Ligand | BDBM175259 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | In Vitro Inhibition Assay | ||
IC50 | 424±0 nM | ||
Citation | Carry, J; Chatreaux, F; Deprets, S; Duclos, O; Leroy, V; Mallart, S; Melon-Manguer, D; Mendez-Perez, M; Vergne, F Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof US Patent US9115140 Publication Date 8/25/2015 | ||
More Info.: | Get all data from this article, Assay Method | ||
ALK tyrosine kinase receptor [L1196M] | |||
Name: | ALK tyrosine kinase receptor [L1196M] | ||
Synonyms: | ALK | ALK L1196M | ALK tyrosine kinase receptor (ALK) (L1196M) | ALK tyrosine kinase receptor (ALK)(L1196M) | ALK tyrosine kinase receptor (L1196M) | ALK_HUMAN | Anaplastic lymphoma kinase L1196M (ALK L1196M) | Tyrosine-protein kinase receptor [L1196M] | ||
Type: | n/a | ||
Mol. Mass.: | 176471.13 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9UM73[L1196M] | ||
Residue: | 1620 | ||
Sequence: |
| ||
BDBM175259 | |||
n/a | |||
Name | BDBM175259 | ||
Synonyms: | US9115140, I-180 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H29N5O4S | ||
Mol. Mass. | 531.626 | ||
SMILES | COc1ccccc1-c1c(sc2cnc(Nc3cc4CCCC(=O)N(C)c4cc3OC(C)C)nc12)C(N)=O |(3.49,-4.12,;3.01,-5.58,;4.04,-6.72,;5.55,-6.4,;6.58,-7.55,;6.11,-9.01,;4.6,-9.33,;3.57,-8.19,;2.06,-8.51,;1.44,-9.92,;-.1,-9.76,;-.42,-8.25,;-1.75,-7.48,;-1.75,-5.94,;-.42,-5.17,;-.42,-3.63,;.92,-2.86,;2.25,-3.63,;3.59,-2.86,;4.79,-3.82,;6.29,-3.48,;6.96,-2.09,;6.29,-.7,;7.25,.5,;4.79,-.36,;4.45,1.14,;3.59,-1.32,;2.25,-.55,;.92,-1.32,;-.42,-.55,;-1.75,-1.32,;-1.75,-2.86,;-3.08,-.55,;.92,-5.94,;.92,-7.48,;2.21,-11.25,;3.75,-11.25,;1.44,-12.58,)| | ||
Structure |